Eugia Pharma Specialities Limited - Company Profile

It is a pharma public limited company based in Ameerpet, Telangana, India, established in 2013.

2013 Ameerpet, Telangana, India Active

Last Updated: January 06, 2026

About Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited, a active public limited company, was established on 17 April 2013 in Ameerpet, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24297TG2013PLC087048. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹800.00 Cr and a paid-up capital of ₹621.01 Cr.

It upholds a compliant status. Employing 2,763 professional, Its leadership includes Madan Mohan Reddy Mettu (Director), Veerayya Chowdary Kosaraju (Director), Yugandhar Puvvala (Ceo). Past directors included Vinod Kumar Reddy Aerva, Vivek Kaushik, Sanjeev Indravadan Dani. It holds no open charges and ₹724.00 Cr settled loans. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.2, Maitrivihar,, Ameerpet, Telangana, 500038.

Company Details

CIN/LLPIN
U24297TG2013PLC087048
Registration Number
087048
Incorporation Date
17 April 2013
Authorized Capital
₹800.00 Cr
Paid-Up Capital
₹621.01 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 800.00 Cr as on 06-01-2026
Paid Up Capital ₹ 621.01 Cr as on 06-01-2026
Company Age 12 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 724.00 Cr as on 06-01-2026
Revenue Growth **** 55.49% (FY 2024)
Profit Growth **** 198.90% (FY 2024)
Ebitda **** 113.19% (FY 2024)
Net Worth 68.12% (FY 2024)
Total Assets **** 7.53% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Eugia Pharma Specialities Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Eugia Pharma Specialities Limited?

Current Directors

Name	Designation	Appointment Date	Status
Madan Mohan Reddy Mettu	Director	17 Apr 2013	Current
Veerayya Chowdary Kosaraju	Director	01 Dec 2021	Current
Yugandhar Puvvala	Ceo	01 Oct 2021	Current
Santhanam Subramanian	Director	01 Oct 2021	Current
Ragunathan Kannan	Director	01 Dec 2021	Current
Sundari Raviprasad Pisupati	Director	01 Dec 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	16 Oct 2017	Past
Pramod Abcsdd	Alternate Director	24 Jan 2018	Past
Pramod Abcsdd	Director	01 Oct 2021	Past
Pramod Abcsdd	Director	25 Jun 2015	Past
Pramod Abcsdd	Additional Director	24 Aug 2015	Past
Pramod Abcsdd	Whole-Time Director	01 Oct 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eugia Pharma Specialities.

Eugia Pharma Specialities Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 55.49% increase. The company also saw a substantial improvement in profitability, with a 198.9% increase in profit. The company's net worth Soared by an impressive increase of 68.12%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

55.49%

*******

Revenue from Operations

*******

56.42%

*******

Total Assets

*******

7.53%

*******

Profit or Loss

*******

198.90%

*******

Net Worth

*******

68.12%

*******

EBITDA

*******

113.19%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eugia Pharma Specialities?

In 2024, Eugia Pharma Specialities had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹7,240,000,000.00

Charges Breakdown by Lending Institutions

Others : 605.00 Cr
Export Import Bank Of India : 119.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Sep 2019	Others	₹105.00 Cr	Satisfied
06 Jul 2017	Others	₹500.00 Cr	Satisfied
24 Feb 2014	Export Import Bank Of India	₹119.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Eugia Pharma Specialities?

Eugia Pharma Specialities has a workforce of 2763 employees as of Feb 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Eugia Pharma Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugia Pharma Specialities's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eugia Pharma Specialities

Recent Activity within the Organization

Annual General Meeting

Eugia Pharma Specialities Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was recorded as a recent event.
08 Sep 2025
Balance Sheet

Progress on Eugia Pharma Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Director Appointment

Vallamkondu Aravind Kumar was appointed as a Cfo was appointed as a Cfo on 21 Feb 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
21 Feb 2024
Charges

A charge registered on 27 Sep 2019 via Charge ID 100295568 with Others was fully satisfied on 04 Mar 2022. was recorded as a recent event.
04 Mar 2022
Director Appointment

Yugandhar Puvvala was appointed as a CEO was appointed as a CEO on 27 Dec 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
27 Dec 2021
Director Appointment

The activity Veerayya Chowdary Kosaraju was appointed as a Director was appointed as a Director on 01 Dec 2021 & has been associated with this company since 4 years 2 months . was completed.
01 Dec 2021

Explore recent activity and updates - View Recent Activity